We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VONE icon
3251
Vanguard Russell 1000 ETF
VONE
$8.55B
$2K ﹤0.01%
+13
New +$1.55K
VPV icon
3252
Invesco Pennsylvania Value Municipal Income Trust
VPV
$193M
$2K ﹤0.01%
+200
New +$2.43K
WERN icon
3253
Werner Enterprises
WERN
$2.23B
$2K ﹤0.01%
51
-5,260
-99% -$191K
WKHS icon
3254
Workhorse Group
WKHS
$37.1M
0
WSR
3255
DELISTED
Whitestone REIT
WSR
$2K ﹤0.01%
169
-6,165
-97% -$87.1K
RVNC
3256
DELISTED
Revance Therapeutics, Inc.
RVNC
$2K ﹤0.01%
46
-3,104
-99% -$89.1K
ENLC
3257
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$2K ﹤0.01%
100
-12,476
-99% -$205K
HMNF
3258
DELISTED
HMN Financial Inc
HMNF
$2K ﹤0.01%
102
-135
-57% -$2.5K
BIG
3259
DELISTED
Big Lots, Inc.
BIG
$2K ﹤0.01%
33
-3,684
-99% -$200K
IMGN
3260
DELISTED
Immunogen Inc
IMGN
$2K ﹤0.01%
299
-269
-47% -$1.66K
SRC
3261
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$2K ﹤0.01%
+46
New +$1.75K
HVBC
3262
DELISTED
HV Bancorp, Inc. Common Stock
HVBC
$2K ﹤0.01%
+100
New +$1.5K
ALBO
3263
DELISTED
Albireo Pharma Inc
ALBO
$2K ﹤0.01%
65
+23
+55% +$583
VIVE
3264
DELISTED
VIVEVE MED INC
VIVE
-4
Closed -$20.8K
DRE
3265
DELISTED
Duke Realty Corp.
DRE
$2K ﹤0.01%
64
-1
-2% -$28
GWGH
3266
DELISTED
GWG Holdings, Inc
GWGH
$2K ﹤0.01%
+300
New +$2.88K
GSS
3267
DELISTED
Golden Star Resources Ltd.
GSS
$2K ﹤0.01%
449
-5,810
-93% -$23.5K
LORL
3268
DELISTED
Loral Space and Communications, Inc.
LORL
$2K ﹤0.01%
54
-664
-92% -$31.1K
CLDR
3269
DELISTED
Cloudera, Inc.
CLDR
$2K ﹤0.01%
100
-2,062
-95% -$33.2K
SYKE
3270
DELISTED
SYKES Enterprises Inc
SYKE
$2K ﹤0.01%
66
-3,825
-98% -$115K
MMAC
3271
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$2K ﹤0.01%
92
+78
+557% +$1.98K
WDR
3272
DELISTED
Waddell & Reed Financial, Inc.
WDR
$2K ﹤0.01%
100
-5,807
-98% -$118K
FIT
3273
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2K ﹤0.01%
400
-26,464
-99% -$168K
WPX
3274
DELISTED
WPX Energy, Inc.
WPX
$2K ﹤0.01%
+117
New +$1.42K
FRAN
3275
DELISTED
Francesca's Holdings Corporation
FRAN
$2K ﹤0.01%
23
-995
-98% -$83.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.